Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Joseph Gunnet"'
Autor:
Raul C. Camacho, Seohee You, Katharine E. D’Aquino, Wenyu Li, Yuanping Wang, Joseph Gunnet, James Littrell, Jian Shen Qi, Lijuan Kang, Wenying Jian, Mary MacDonald, Timothy Tat, Derek Steiner, Yue-Mei Zhang, James Lanter, Raymond Patch, Rui Zhang, Jiali Li, Suzanne Edavettal, Wilson Edwards, Thai Dinh, Li Ying Wang, Judy Connor, Michael Hunter, Ellen Chi, Ronald V. Swanson, James N. Leonard, Martin A. Case
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
The long circulating half-life and inherently bivalent architecture of IgGs provide an ideal vehicle for presenting otherwise short-lived G-protein-coupled receptor agonists in a format that enables avidity-driven enhancement of potency. Here, we des
Externí odkaz:
https://doaj.org/article/5eb7ffd685414dc1807d86d35890f6a4
Autor:
Jian Shen Qi, Thai Dinh, Timothy Tat, James Littrell, Ronald V. Swanson, Raul C. Camacho, Mary MacDonald, Ellen Chi, Lijuan Kang, Derek Steiner, Katharine D'Aquino, Jiali Li, Wenying Jian, Yue-Mei Zhang, James N. Leonard, Li Ying Wang, Yuanping Wang, Suzanne Edavettal, Michael J. Hunter, Wenyu Li, Case Martin A, Joseph Gunnet, Raymond J. Patch, Seohee You, Judy Connor, Wilson Edwards, Zhang Rui, James C. Lanter
Publikováno v:
mAbs
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The long circulating half-life and inherently bivalent architecture of IgGs provide an ideal vehicle for presenting otherwise short-lived G-protein-coupled receptor agonists in a format that enables avidity-driven enhancement of potency. Here, we des
Autor:
Zhihua Sui, William V. Murray, Celia Jenkinson, Norman D. Huebert, Peter Haug, Michael P. Winters, Wen Yan, James N. Leonard, Yuanping Wang, Arthur T. Suckow, Austin Bell, Tatiana Koudriakova, Hong Hua, Wilmelenne Clapper, Wall Mark, Joseph Gunnet
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:841-846
The discovery of a novel series of N-arylpyrroles as agonists of GPR120 (FFAR4) is discussed. One lead compound is a potent GPR120 agonist, has good selectivity for related receptor GPR40 (FFAR1), has acceptable PK properties, and is active in 2 mode
Design, synthesis and SAR of a novel series of heterocyclic phenylpropanoic acids as GPR120 agonists
Autor:
Austin Bell, Hong Hua, Wen Yan, Chaozhong Cai, Celia Jenkinson, Peter Haug, Wall Mark, Yuanping Wang, Imad Nashashibi, Xuqing Zhang, Arthur T. Suckow, Michael P. Winters, James N. Leonard, Michele Wells, Joseph Gunnet, William V. Murray, Zhihua Sui, Jingyuan Ma, James C. Lanter, Wilma Clapper, Aaron Novack
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 27:3272-3278
A novel series of 5-membered heterocycle-containing phenylpropanoic acid derivatives was discovered as potent GPR120 agonists with low clearance, high oral bioavailability and in vivo antidiabetic activity in rodents.
Autor:
Wall Mark, Celia Jenkinson, Zhihua Sui, Michael P. Winters, Tatiana Koudriakova, Norman D. Huebert, James N. Leonard, Yuanping Wang, Austin Bell, Hong Hua, Peter Haug, William V. Murray, Joseph Gunnet, Wilmelenne Clapper, Wen Yan, Arthur T. Suckow
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:1676-1678
Autor:
Zhihua Sui, Yuanping Wang, Xuqing Zhang, Mark J. Macielag, Hong Hua, Wen Yan, Peter Haug, Austin Bell, Joseph Gunnet, Chaozhong Cai, Celia Jenkinson, William V. Murray, James N. Leonard, Arthur T. Suckow, Wilma Clapper
We have discovered a novel series of isothiazole-based phenylpropanoic acids as GPR120 agonists. Extensive structure–activity relationship studies led to the discovery of a potent GPR120 agonist 4x, which displayed good EC50 values in both calcium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7ef3b314c5a726bc0646f755898f00a
https://europepmc.org/articles/PMC5601374/
https://europepmc.org/articles/PMC5601374/